No single canonical receptor binds the peptide with high affinity, and the systems-level pharmacology that defines the compound continues to be an active research question
BPC-157 acts primarily at the tissue and gut level - more localised, faster-acting on specific injury sites and gut lining
For instance: Concentrated liquid medicines that contain multiple uses may require dilution with bacteriostatic water
Dong M, Deganutti G, Piper SJ, Liang YL, Khoshouei M, Belousoff MJ, et al
Instead, a trigger pushes many follicles out of the growth phase (anagen) and into the resting phase (telogen) at once, so shedding typically appears about 23 months after the event and then gradually improves as the cycle resets [5]
(1993) published the foundational study characterizing BPC-157s cytoprotective effects in a rat gastric lesion model